Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. (KRTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · KRTX · as of Mar 31, 2024
Ownership Breakdown
3
Institutional Holders
▼ 360 vs Q4
$297,642
Total Inst. Value
▼ $12.00B vs Q4
38.20M
Shares Outstanding
freeFloat 94.94%
906
13F Shares Held
▼ 37.91M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
KRTX largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
IFP ADVISORS, INC pharmaceutical preparations | 817 | 0.22% | 0.22% | $269.47M | Jul 30, 2024 | ▼ 3 |
EVERSOURCE WEALTH ADVISORS, LLC pharmaceutical preparations | 88 | 0.02% | 0.02% | $27.85M | May 13, 2024 | — held |
SACHETTA, LLC pharmaceutical preparations | 1 | 0.00% | 0.00% | $317,000 | May 1, 2024 | — held |
BANK OF NOVA SCOTIA pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
JPMORGAN CHASE & CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Dec 26, 2024 | EXIT |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 8, 2024 | EXIT |
PRINCIPAL SECURITIES, INC. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
FRANKLIN RESOURCES INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2024 | EXIT |
CENTRAL TRUST CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Apr 24, 2024 | EXIT |
M&T BANK CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 7, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares0
New Positions
first time holders1
Decreased
−3 shares47
Sold Out
fully exitedNet shares change (top 50)
3
+0 / −3
Net new holders
-48
0 new / 47 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
KRTX insider trading · insider activity
Source: SEC Form 4
18
Buy transactions
107
Sell transactions
0.17
Buy/Sell ratio
$4M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Wheadon David E. director | Mar 18, 2024 | D-Return | 25,000 | $94.56 | $2.36M | 0 | Form 4 ↗ |
Wheadon David E. director | Mar 18, 2024 | D-Return | 8,500 | $128.01 | $1.09M | 0 | Form 4 ↗ |
Wheadon David E. director | Mar 18, 2024 | D-Return | 990 | $330.00 | $326.7K | 0 | Form 4 ↗ |
Wheadon David E. director | Mar 18, 2024 | D-Return | 5,000 | $102.96 | $514.8K | 0 | Form 4 ↗ |
Wheadon David E. director | Mar 18, 2024 | D-Return | 1,904 | $237.70 | $452.6K | 0 | Form 4 ↗ |
Torres Denice director | Mar 18, 2024 | D-Return | 990 | $330.00 | $326.7K | 0 | Form 4 ↗ |
Torres Denice director | Mar 18, 2024 | D-Return | 5,000 | $102.96 | $514.8K | 0 | Form 4 ↗ |
Torres Denice director | Mar 18, 2024 | D-Return | 1,904 | $237.70 | $452.6K | 0 | Form 4 ↗ |
Torres Denice director | Mar 18, 2024 | D-Return | 8,500 | $128.01 | $1.09M | 0 | Form 4 ↗ |
Torres Denice director | Mar 18, 2024 | D-Return | 25,000 | $104.26 | $2.61M | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Karuna Therapeutics, Inc. (KRTX) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 5.06%, while retail and public investors account for the remaining 94.94%.
The largest institutional shareholder of Karuna Therapeutics, Inc. is IFP ADVISORS, INC, holding approximately 817 shares — equal to 0.22% of outstanding shares — as of March 31, 2024.
A total of 3 institutional investors currently hold KRTX stock, with a combined institutional value of approximately $297,642 as of the most recent 13F filing period.
Frequently asked questions
KRTX ownershipKaruna Therapeutics, Inc. (KRTX) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is IFP ADVISORS, INC with a 0.22% stake. Company insiders hold 5.06%. Data sourced from SEC Form 13F as of March 31, 2024.